Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) LSE

8.40

+0.2(+2.44%)

Updated at December 24 05:48PM

Currency In USD

Valuation

Market Cap128.8M
Enterprise Value114.84M
P/E Ratio-1.78
PEG Ratio-0.06
Price/Sales Ratio150.24
Price/Book Ratio0.93
Enterprise/Revenue125.23
Enterprise/EBITDA-1.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-82.39
Operating Margin-95.31

Management Effectiveness

Return On Assets-0.46
Return On Equity-0.44

Income Statement

Revenue0
Revenue/Share0.06
Gross Profit-600,000
EBITDA-37.74M
Net Income-40.21M
Diluted EPS-3.68

Balance Sheet

Total Cash26.98M
Total Cash/Share9.53
Total Debt2.05M
Total Debt/Equity0.02
Current Ratio9.21
Book Value Per Share9.07

Price History

52-Week Change-33.21
52-Week High49.65
52-Week Low2.82
Moving Average 50 Days21.54
Moving Average 200 Days10.76

Statistics

Average Volume3,322
Shares Outstanding12.54M
% Held by Institutions71.9

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor33333:1000000
Last Split DateFebruary 14, 2023